Proximal Tubule Secretory Clearance, Injury, and Kidney Viability in Cirrhosis.


Journal

Clinical and translational gastroenterology
ISSN: 2155-384X
Titre abrégé: Clin Transl Gastroenterol
Pays: United States
ID NLM: 101532142

Informations de publication

Date de publication:
07 Oct 2024
Historique:
received: 09 04 2024
accepted: 18 09 2024
medline: 7 10 2024
pubmed: 7 10 2024
entrez: 7 10 2024
Statut: aheadofprint

Résumé

Cirrhosis affects all structures of the kidney, in particular the tubules which are responsible for secretion of protein-bound metabolites and electrolyte/water homeostasis. Yet, prevailing assessments of kidney function focus solely on glomerular filtration rate (GFR) which may incompletely reflect these processes. We sought to characterize markers of tubular function, injury, and viability in patients with and without cirrhosis. We recruited outpatients undergoing liver transplantation evaluation for a collection of plasma and 24-hour urine, matching by GFR to control participants without cirrhosis. We measured urinary kidney injury molecule-1 (KIM-1), a marker of proximal tubular injury, as well as epidermal growth factor (EGF), a marker of viability necessary for tubular epithelial cell proliferation after injury. We also estimated secretory clearance by measuring several highly secreted endogenous metabolites in urine and plasma. We recruited 39 patients with cirrhosis (mean MELD-Na 17±4, Child-Pugh 8±2, eGFR 66±20 ml/min/1.73m2) and 58 GFR-matched controls without cirrhosis (eGFR 66±21 ml/min/1.73m2). Urinary KIM-1 was 4.4-fold higher than controls (95% CI:2.9-6.5), and EGF averaged 7.41-fold higher than controls (95% CI:2.15-25.53). We found that of 8 solutes, 5 had significantly greater kidney clearance in cirrhosis (1.3-2.1-fold higher): indoxyl sulfate, p-cresol sulfate, pyridoxic acid, tiglylglycine, and xanthosine. Cirrhosis was characterized by molecular signs of tubular injury in stable outpatients without acute kidney injury, accompanied by largely preserved tubular secretory clearance and greater signs of tubular viability. Within the limitations of the study, this suggests a phenotype of chronic ischemic injury but with initial preservation of tubular function in cirrhosis.

Identifiants

pubmed: 39374041
doi: 10.14309/ctg.0000000000000775
pii: 01720094-990000000-00315
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : University of Washington
ID : C-LIFE

Informations de copyright

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.

Auteurs

Michael L Granda (ML)

Division of Nephrology, Department of Medicine, University of Washington, Seattle WA.
Kidney Research Institute, University of Washington, Seattle, WA.

Eric Luitweiler (E)

Division of Nephrology, Department of Medicine, University of Washington, Seattle WA.

David K Prince (DK)

Kidney Research Institute, University of Washington, Seattle, WA.

Andrew S Allegretti (AS)

Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA.

Cary Paine (C)

Division of Nephrology, Department of Medicine, University of Washington, Seattle WA.

Raimund Pichler (R)

Division of Nephrology, Department of Medicine, University of Washington, Seattle WA.

Lena Sibulesky (L)

Division of Transplant Surgery, Department of Surgery, University of Washington, Seattle, WA.

Scott W Biggins (SW)

Division of Gastroenterology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.

Bryan Kestenbaum (B)

Division of Nephrology, Department of Medicine, University of Washington, Seattle WA.
Kidney Research Institute, University of Washington, Seattle, WA.

Classifications MeSH